One Case Report and Literature Review of Adrenocortical Carcinoma

doi:10.12114/j.issn.1007-9572.2018.00.161

Abstract

Abstract: Adrenocortical carcinoma is a rare disease with poor prognosis.After retrospecting the history of a case diagnosed adrenocortical carcinoma and researching the literature related，the author provide the reference of the way to heal Adrenocortical carcinoma，by summarizing the diagnosis，surgery method and other adjuvant therapeutic schedule of this disease.

Key words: Adrenocortical carcinoma, Diagnosis, Case reports

摘要： 肾上腺皮质癌在临床上少见，其预后较差，本文通过报道1例肾上腺皮质癌病历资料及复习相关文献，总结该疾病的诊断、手术方式及其他辅助治疗方案、预后，为临床上选择肾上腺皮质癌的诊疗方法提供参考。

关键词: 肾上腺皮质癌, 诊断, 病例报告

SUN Liangxue,CHEN Linxi,MO Licai. One Case Report and Literature Review of Adrenocortical Carcinoma　[J]. Chinese General Practice, 2018, 21(30): 3776-3781. DOI: 10.12114/j.issn.1007-9572.2018.00.161.
孙良学,陈林喜,莫利才. 肾上腺皮质癌一例报道并文献复习[J]. 中国全科医学, 2018, 21(30): 3776-3781. DOI: 10.12114/j.issn.1007-9572.2018.00.161.

References

［1］张天泽，徐光炜．肿瘤学（下册）［M］．天津：天津科学技术出版杜，1997.3779
［2］LINDHOLM J，JUUL S，J?RGENSEN J O，et al．Incidence and late prognosis of cushing's syndrome：a population-based study［J］．J Clin Endocrinol Metab，2001，86（1）：117-123．DOI：10.1210/jcem.86.1.7093.3779
［3］ABIVEN G，COSTE J，GROUSSIN L，et al．Clinical and biological features in the prognosis of adrenocortical cancer：poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients［J］．J Clin Endocrinol Metab，2006，91（7）：2650-2655．DOI：10.1210/jc.2005-2730.3779
［4］FASSNACHT M，JOHANSSEN S，QUINKLER M，et al．Limited prog-nostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma：proposal for a Revised TNM Classification［J］．Cancer，2009，115（2）：243-250．DOI：10.1002/cncr.24030.3779
［5］GAUJOUX S，MIHAI R，Joint Working Group of ESES and ENSAT.European Society of Endocrine Surgeons （ESES） and European Network for the Study of Adrenal Tumours （ENSAT） recom-mendations for the surgical management of adrenocortical carcinoma［J］．Br J Surg，2017，104（4）：358-376．DOI：10.1002/bjs.10414.3779
［6］KOROBKIN M，BRODEUR F J，FRANCIS I R，et al．CT time-attenuation washout curves of adrenal adenomas and nonadenomas［J］．AJR Am J Roentgenol，1998，170（3）：747-752．DOI：10.2214/ajr.170.3.9490968.3780
［7］KOROBKIN M，BRODEUR F J，FRANCIS I R，et al．Delayed enhanced CT for differentiation of benign from malignant adrenal masses［J］．Radiology，1996，200（3）：737-742．DOI：10.1148/radiology.200.3.8756924.3780
［8］TENENBAUM F，GROUSSIN L，FOEHRENBACH H，et al．18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients［J］． Eur J Endocrinol，2004，150（6）：789-792.3780
［9］HENRY J F，PEIX J L，KRAIMPS J L.Positional statement of the European Society of Endocrine Surgeons （ESES） on malignant adrenal tumors［J］．Langenbecks Arch Surg，2012，397（2）：145-146．DOI：10.1007/s00423-011-0893-5.3780
［10］BERRUTI A，BAUDIN E，GELDERBLOM H，et al．Adrenal cancer：ESMO clinical practice guidelines for diagnosis，treatment and follow-up［J］． Ann Oncol，2012，23 Suppl 7：vii131-138．DOI：10.1093/annonc/mds231.3780
［11］DY B M，STRAJINA V，CAYO A K，et al．Surgical resection of synchronously metastatic adrenocortical cancer［J］．Ann Surg Oncol，2015，22（1）：146-151．DOI：10.1245/s10434-014-3944-7.3780
［12］DIDOLKAR M S，BESCHER R A，ELIAS E G，et al．Natural history of adrenal cortical carcinoma：a clinicopathologic study of 42 patients［J］．Cancer，1981，47（9）：2153-2161.3780
［13］FASSNACHT M，TERZOLO M，ALLOLIO B，et al．Combination chemotherapy in advanced adrenocortical carcinoma［J］．N Engl J Med，2012，366（23）：2189-2197．DOI：10.1056/NEJMoa1200966.3780
［14］BERRUTI A，TERZOLO M，SPERONE P，et al．Etoposide，doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma：a large prospective phase Ⅱ trial［J］．Endocr Relat Cancer，2005，12（3）：657-666．DOI：10.1677/erc.1.01025.3780
［15］GRATIAN L，PURA J，DINAN M，et al．Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States［J］．Ann Surg Oncol，2014，21（11）：3509-3514．DOI：10.1245/s10434-014-3931-z.3780
［16］LOMBARDI C P，RAFFAELLI M，BONIARDI M，et al．Adrenocortical carcinoma：effect of hospital volume on patient outcome［J］．Langenbecks Arch Surg，2012，397（2）：201-207．DOI：10.1007/s00423-011-0866-8.3780
［17］GRECO F，HODA M R，RASSWEILER J，et al．Laparoscopic adrenalectomy in urological centres-the experience of the German Laparoscopic working group［J］．BJU Int，2011，108（10）：1646-1651．DOI：10.1111/j.1464-410X.2010.10038.x.3780
［18］IINO K，OKI Y，SASANO H.A case of adrenocortical carcinoma associated with recurrence after laparoscopic surgery［J］．Clin Endocrinol（Oxf），2000，53（2）：243-248.3780
［19］JANY T，CHEVALLIER C，PATTOU F.Transthoracic transdiaphragmatic approach for resection or large right sided adrenal tumors［J］．J Chir（Paris），2007，144（6）：527-531.3780
［20］VANBRUGGHE C，LOWERY A J，GOLFFIER C，et al．Adrenocortical carcinoma surgery-surgical extent and approach［J］．Langenbecks Arch Surg，2016，401（7）：991-997．DOI：10.1007/s00423-016-1462-8.3780
［21］AMINI N，MARGONIS G A，KIM Y，et al．Curative resection of adrenocortical carcinoma：rates and patterns of postoperative recurrence［J］．Ann Surg Oncol，2016，23（1）：126-133．DOI：10.1245/s10434-015-4810-y.3780
［22］KIM Y，MARGONIS G A，PRESCOTT J D，et al．Nomograms to predict recurrence-free and overall survival after curative resection of adrenocortical carcinoma［J］．JAMA Surg，2016，151（4）：365-373．DOI：10.1001/jamasurg.2015.4516.3780
［23］MARGONIS G A，KIM Y，PRESCOTT J D，et al．Adrenocortical carcinoma：impact of surgical margin status on long-term outcomes［J］．Ann Surg Oncol，2016，23（1）：134-141．DOI：10.1245/s10434-015-4803-x.3780
［24］MILLER B S，GAUGER P G，HAMMER G D，et al．Resectionof adrenocortical carcinoma is less complete and loca recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy［J］．Surgery，2012，152（6）：1150-1157．DOI：10.1016/j.surg.2012.08.024.3780
［25］REIBETANZ J，JUROWICH C，ERDOGAN I，et al．Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma［J］．Ann Surg，2012，255（2）：363-369．DOI：10.1097/SLA.0b013e3182367ac3.3780
［26］SAADE N，SADLER C，GOLDFARB M.Impact of regional lymph node dissection on disease specific survival in adrenal cortical carcinoma［J］．Horm Metab Res，2015，47（11）：820-825.DOI：10.1055/s-0035-1549877.3780
［27］MARGONIS G A，KIM Y，TRAN T B，et al．Outcomes after resection of cortisol-secreting adrenocortical carcinoma［J］．Am J Surg，2016，211（6）：1106-1113．DOI：10.1016/j.amjsurg.2015.09.020.3780
［28］MARGONIS G A，AMINI N，KIM Y，et al．Incidence of perioperative complications following resection of adrenocortical carcinoma and its association with long-term survival［J］． World J Surg，2016，40（3）：706-714．DOI：10.1007/s00268-015-3307-y.3780
［29］BEUSCHLEIN F，WEIGEL J，SAEGER W，et al．Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection［J］．J Clin Endocrinol Metab，2015，100（3）：841-849．DOI：10.1210/jc.2014-3182.3780
［30］ASSIé G，ANTONI G，TISSIER F，et al．Prognostic parameters of metastatic adrenocortical carcinoma［J］．J Clin Endocrinol Metab，2007，92（1）：148-154．DOI：10.1210/jc.2006-0706.3780
［31］GAUJOUX S，GRABAR S，FASSNACHT M，et al．β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma［J］．Clin Cancer Res，2011，17（2）：328-336．DOI：10.1158/1078-0432.CCR-10-2006.3780
［32］KIM Y，MARGONIS G A，PRESCOTT J D，et al．Curative surgical resection of adrenocortical carcinoma：determining long-term outcome based on conditional disease-free probability［J］．Ann Surg，2017，265（1）：197-204．DOI：10.1097/SLA.0000000000001527.3781
［33］TRAN T B，MAITHEL S K，PAWLIK T M，et al．Clinical scorepredicting long-term survival after repeat resection for recurrent adrenocortical carcinoma［J］．J Am Coll Surg，2016，223（6）：794-803．DOI：10.1016/j.jamcollsurg.2016.08.568.3781
［34］BELLANTONE R，FERRANTE A，BOSCHERINI M，et al．Role of reoperation in recurrence of adrenal cortical carcinoma：results from 188 cases collected in the Italian National Registry for adrenal cortical carcinoma［J］．Surgery，1997，122（6）：1212-1218.3781
［35］KWAUK S，BURT M.Pulmonary metastases from adrenal cortical carcinoma：results of resection［J］．J Surg Oncol，1993，53（4）：243-246.3781
［36］BEDNARSKI B K，HABRA M A，PHAN A，et al．Borderline resectable adrenal cortical carcinoma：a potential role for preoperative chemotherapy［J］．World J Surg，2014，38（6）：1318-1327．DOI：10.1007/s00268-014-2484-4.3781
［37］BAUDIN E，PELLEGRITI G，BONNAY M，et al．Impact of monitoring plasma 1，1-dichlorodiphenildichloroethane （o，p'DDD） levels on the treatment of patients with adrenocortical carcinoma［J］．Cancer，2001，92（6）：1385-1392.3781
［38］ALLOLIO B，FASSNACHT M.Clinical review：adrenocortical carcinoma：clinical update［J］．J Clin Endocrinol Metab，2006，91（6）：2027-2037．DOI：10.1210/jc.2005-2639.3781
［39］TERZOLO M，ANGELI A，FASSNACHT M，et al．Adjuvant mitotane treatment for adrenocortical carcinoma［J］．N Engl J Med，2007，356（23）：2372-2380．DOI：10.1056/NEJMoa063360.3781

[1]	HONG Yuchun, WU Hua, DU Yishan, LI Shuran, SUN Wenmin, YE Mingyu, ZHANG Yongjian, LI Yang. Development of General Practice Diagnostic Terminology and Coding and Empirical Study on Its Application [J]. Chinese General Practice, 2023, 26(31): 3896-3901.
[2]	CHEN Jing, ZOU Tao, ZHAO Danqing, XIAO Ziwen, WU Xianqing, Chinese Medical Association Psychosomatic Medicine Branch Perinatal Mental Disorders Collaborative Group. Expert Consensus on Screening, Diagnosis and Treatment of Perinatal Mental Disorders [J]. Chinese General Practice, 2023, 26(28): 3463-3470.
[3]	YIN Zhaoxia, KONG Chongyu, ZOU Xianhui, LI Chuang, HUANG Yin, FENG Yang, WANG Yunfei, GONG Weijie. Traditional Chinese Medicine Disease Spectrum Analysis in Outpatient Clinics of Contracted Residents by Family Doctors in Shenzhen Community Health Service Centers [J]. Chinese General Practice, 2023, 26(25): 3112-3117.
[4]	BAO Yiru, BAO Shouqian, ZHANG Zhaohui, ZHANG Yinchuan. Tetanus with Low back and Knee Pain, Abdominal Distension and Constipation as Initial Presentations: Report of a Deaf and Mute Case and Literature Review [J]. Chinese General Practice, 2023, 26(24): 3074-3078.
[5]	ZHANG Yanjing, SONG Xiaokun. Ideas for the Diagnosis and Treatment of Multisystem Immune-related Adverse Events Caused by Immune Checkpoint Inhibitors [J]. Chinese General Practice, 2023, 26(23): 2930-2935.
[6]	ZHANG Yunxu, WANG Tingting, WEI Junling, XING Yanyun, SU Li. A Newly Discovered Disease Affecting Women's Physical and Mental Health: Research Status and Expert Consensus Interpretation of Persistent Genital Arousal Disorder [J]. Chinese General Practice, 2023, 26(23): 2830-2835.
[7]	RAO Yufeng, MENG Liheng, ZHOU Jia, LIANG Xinghuan, HUANG Zhenxing, QIN Yingfen. Phenotypically Male Congenital Adrenal Hyperplasia Patient with Huge Space-occupying Adrenal Masses: a Case Report and Literature Review [J]. Chinese General Practice, 2023, 26(21): 2690-2694.
[8]	HU Xiaofei, ZHAO Ping, CAO Tinghua, PENG Lanlan. Study on the Predictive Value of Abdominal Fat Content and Distribution in the Acute Pancreatitis and Its Severity [J]. Chinese General Practice, 2023, 26(21): 2614-2619.
[9]	TANG Binzhi, YANG Qian, LING Qiying, LI Maojun, SHI Wei, WU Qing. Early Postnatal Management of an Extremely Low Birth Weight Periviable Infant [J]. Chinese General Practice, 2023, 26(20): 2559-2566.
[10]	SHEN Junxi, ZHU Xing, CHEN Yunzhi, LI Wen. Novel Developments in Lung and Gut Microbiota and Their Cross-talk with the Development of Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2023, 26(20): 2548-2554.
[11]	REN Yumei, XU Min, YE Meilei, ZHANG Qiu, HU Honglin. A Mutation in the Insulin Receptor Substrate 2 Gene May Be Associated with Maturity-onset Diabetes of the Young: a Case Report with Genetic Analysis [J]. Chinese General Practice, 2023, 26(18): 2301-2305.
[12]	WANG Hai, WANG Zhuoli, PEI Honghong, PAN Longfei. Analysis of Risk Factors and Exploration of Predictors of Serious Cases of COVID-19 in Xi'an during the Period of 2021-2022 [J]. Chinese General Practice, 2023, 26(17): 2132-2137.
[13]	XU Bixia, YAO Weiguang. Changes in Patient Visits and Associated Determinants in Primary Healthcare Settings in Guangdong: a Grey Relational Analysis [J]. Chinese General Practice, 2023, 26(16): 1965-1971.
[14]	LI Yafeng. Clinical Manifestations and Experience of Diagnosis and Treatment of Lymphoid Tissue Infection Caused by Pseudomonas Aeruginosa [J]. Chinese General Practice, 2023, 26(15): 1923-1926.
[15]	Chinese Society of Osteoporosis and Bone Mineral Research. Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022) [J]. Chinese General Practice, 2023, 26(14): 1671-1691.